Bernard Lespérance

1.9k total citations
17 papers, 387 citations indexed

About

Bernard Lespérance is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Bernard Lespérance has authored 17 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Bernard Lespérance's work include BRCA gene mutations in cancer (6 papers), DNA Repair Mechanisms (2 papers) and Genetic factors in colorectal cancer (2 papers). Bernard Lespérance is often cited by papers focused on BRCA gene mutations in cancer (6 papers), DNA Repair Mechanisms (2 papers) and Genetic factors in colorectal cancer (2 papers). Bernard Lespérance collaborates with scholars based in Canada, United Kingdom and France. Bernard Lespérance's co-authors include Jocelyne Chiquette, Rachel Laframboise, Marie Plante, Paul Bessette, Jacques Simard, Marianne Paesmans, Jorma Isola, Gϋnter von Minckwitz, Euan Walpole and Geneviève Ouellette and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

Bernard Lespérance

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Lespérance Canada 11 182 177 145 91 37 17 387
Farzana L. Walcott United States 11 132 0.7× 125 0.7× 61 0.4× 55 0.6× 31 0.8× 17 295
Elisabetta De Matteis Italy 13 138 0.8× 102 0.6× 146 1.0× 114 1.3× 45 1.2× 33 342
Claudia Arce-Salinas Mexico 11 241 1.3× 138 0.8× 64 0.4× 177 1.9× 47 1.3× 25 448
Jonathan Beesley Australia 10 125 0.7× 166 0.9× 82 0.6× 65 0.7× 38 1.0× 16 350
Laura Lucini Italy 8 233 1.3× 94 0.5× 49 0.3× 62 0.7× 29 0.8× 11 376
Ursula Denison Austria 12 185 1.0× 69 0.4× 59 0.4× 57 0.6× 35 0.9× 30 687
María Carolina Sanabria‐Salas Colombia 11 131 0.7× 66 0.4× 91 0.6× 110 1.2× 55 1.5× 34 289
Serafino Conforti Italy 7 158 0.9× 98 0.6× 194 1.3× 111 1.2× 29 0.8× 15 376
Azadeh Nasrazadani United States 12 180 1.0× 124 0.7× 47 0.3× 101 1.1× 41 1.1× 29 332
Joellen Schildkraut United States 6 153 0.8× 126 0.7× 270 1.9× 144 1.6× 121 3.3× 12 464

Countries citing papers authored by Bernard Lespérance

Since Specialization
Citations

This map shows the geographic impact of Bernard Lespérance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Lespérance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Lespérance more than expected).

Fields of papers citing papers by Bernard Lespérance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Lespérance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Lespérance. The network helps show where Bernard Lespérance may publish in the future.

Co-authorship network of co-authors of Bernard Lespérance

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Lespérance. A scholar is included among the top collaborators of Bernard Lespérance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Lespérance. Bernard Lespérance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dubois, Carl‐Ardy, Roxane Borgès Da Silva, Mélanie Lavoie‐Tremblay, et al.. (2020). Developing and maintaining the resilience of interdisciplinary cancer care teams: an interventional study. BMC Health Services Research. 20(1). 1039–1039. 10 indexed citations
2.
Tehfé, Mustapha, Scot Dowden, Hagen F. Kennecke, et al.. (2016). nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial. Advances in Therapy. 33(5). 747–759. 16 indexed citations
3.
Borduas, Francine, Jocelyne Chiquette, Caroline Diorio, et al.. (2016). Recommendations on Breast Cancer Screening and Prevention in the Context of Implementing Risk Stratification: Impending Changes to Current Policies. Current Oncology. 23(6). 615–625. 33 indexed citations
4.
Lespérance, Bernard, et al.. (2015). Retrospective study on survival of patients with metastatic breast cancer.. Journal of Clinical Oncology. 33(15_suppl). e11545–e11545. 1 indexed citations
5.
Desjardins, Sylvie, Pascal Belleau, Yvan Labrie, et al.. (2007). Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high‐risk non BRCA1/2 French Canadian breast and ovarian cancer families. International Journal of Cancer. 122(1). 108–116. 17 indexed citations
6.
Guénard, Frédéric, Yvan Labrie, Geneviève Ouellette, et al.. (2007). Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families. Familial Cancer. 6(4). 483–490. 21 indexed citations
7.
Samson, C., Paul Bessette, Jocelyne Chiquette, et al.. (2006). No Evidence of BRCA1/2 Genomic Rearrangements in High-Risk French-Canadian Breast/Ovarian Cancer Families. PubMed. 10(2). 104–115. 41 indexed citations
8.
Avard, Denise, Peter J. Bridge, Lucie M. Bucci, et al.. (2006). Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges. Familial Cancer. 5(1). 3–13. 9 indexed citations
9.
Mes‐Masson, Anne‐Marie, Louise Champoux, Josée Hébert, Gerald Batist, & Bernard Lespérance. (2006). [The réseau de recherche sur le cancer: favoring a multi-disciplinary approach].. PubMed. 93(9). 831–4. 1 indexed citations
10.
Durocher, Francine, Yvan Labrie, Penny Soucy, et al.. (2006). Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families. BMC Cancer. 6(1). 40 indexed citations
11.
Dumont, Martine, Gilles Leblanc, Yvan Labrie, et al.. (2005). A new alternative splice variant of BRCA1 containing an additional in-frame exon. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1731(1). 57–65. 13 indexed citations
12.
Leo, Angelo Di, Stephen Chan, Marianne Paesmans, et al.. (2004). HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel. Breast Cancer Research and Treatment. 86(3). 197–206. 121 indexed citations
13.
Palisaitis, Donald, et al.. (2004). Inhibition of Streptokinase‐Induced, Antibody‐Mediated Platelet Aggregation with Tirofiban After Exposure to Streptokinase or Streptococcal Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(5). 558–563. 1 indexed citations
14.
Labrie, Fernand, Claude Labrie, Jacques Laverdière, et al.. (2004). Activity and Safety of the Antiestrogen EM-800, the Orally Active Precursor of Acolbifene, in Tamoxifen-Resistant Breast Cancer. Journal of Clinical Oncology. 22(5). 864–871. 24 indexed citations
15.
Palisaitis, Donald, et al.. (2003). Platelet activity and antibody titers after exposure to streptokinase or streptococcal infection. Thrombosis Research. 111(4-5). 243–249. 2 indexed citations
16.
Davidson, Neville, Bernardo L. Rapoport, Björn Erikstein, et al.. (1999). Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: A multicenter, double-masked study. Clinical Therapeutics. 21(3). 492–502. 25 indexed citations
17.
Meyer, Ralph M., M Gyger, Ross Langley, Bernard Lespérance, & Stephen Caplan. (1998). A Phase I Trial of Standard and Cyclophosphamide Dose-Escalated CHOP with Granulocyte Colony Stimulating Factor in Elderly Patients with Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 30(5-6). 591–600. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farzana L. Walcott Breakdown of academic impact, for papers by Elisabetta De Matteis Breakdown of academic impact, for papers by Claudia Arce-Salinas Breakdown of academic impact, for papers by Jonathan Beesley Breakdown of academic impact, for papers by Laura Lucini Breakdown of academic impact, for papers by Ursula Denison Breakdown of academic impact, for papers by María Carolina Sanabria‐Salas Breakdown of academic impact, for papers by Serafino Conforti Breakdown of academic impact, for papers by Azadeh Nasrazadani Breakdown of academic impact, for papers by Joellen Schildkraut
Rankless by CCL
2026